Evidence map›Paper›PMID 36527643›Full record

ArticleAdvances in experimental medicine and biology2022

Feasibility of Non-invasive Measurement of Tumour NAD(H) by In Vivo Phosphorus-31 Magnetic Resonance Spectroscopy.

Kavindra Nath, Fernando Arias-Mendoza, He N Xu, Pradeep K Gupta, Lin Z Li

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advances in experimental medicine and biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Kavindra NathBritton Chance Laboratory of Redox Imaging and Laboratory of Molecular Imaging, Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Fernando Arias-MendozaBritton Chance Laboratory of Redox Imaging and Laboratory of Molecular Imaging, Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
He N XuBritton Chance Laboratory of Redox Imaging and Laboratory of Molecular Imaging, Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Pradeep K GuptaBritton Chance Laboratory of Redox Imaging and Laboratory of Molecular Imaging, Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Lin Z LiBritton Chance Laboratory of Redox Imaging and Laboratory of Molecular Imaging, Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. linli@pennmedicine.upenn.edu.
University of Pennsylvania · US

Funding

Redox imaging for breast cancer prognosisR01CA191207 · NCI · UNIVERSITY OF PENNSYLVANIA · PI LI, LIN Z · 2015 to 2019
$3.2M
NCI NIH HHS R01 CA191207
6 · The paper itself

Abstract

Importance of the redox status of nicotinamide adenine dinucleotide (NAD), including its oxidized (NAD

Indexed as

NADNeoplasmsAnimalsFeasibility StudiesHumansMagnetic Resonance SpectroscopyMiceOxidation-ReductionPhosphorusNADPhosphorusOptical redox ratioSolution phantomsxenograft of MAD-MB-231 breast cancer cell linexenografts of MCF-7 and BT474 breast cancer cell line

Identifiers

PMID36527643
PMCPMC11299163
OpenAlexW4312019013

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.